Second African Country Approves the Sputnik V Vaccine

The Russian Direct Investment Fund (RDIF) announced on January 29, 2021, the registration of the Russian vaccine against coronavirus Sputnik V by the National Administration of Pharmaceuticals and Medicines of the Republic of Guinea. The Republic of Guinea is the second African country to approve the Sputnik V vaccine. 

The vaccine was registered as part of an emergency use authorization based on Sputnik V clinical trials in Russia.

Kirill Dmitriev, CEO of the RDIF, said in a press statement, “The Republic of Guinea became the second African state to register the Sputnik V vaccine. High safety and efficacy rates make Sputnik V one of the most demanded vaccines against coronavirus on all continents."

"The drug was created on the well-studied human adenoviral vectors platform and is highly trusted by our partners in the Republic of Guinea. The Sputnik V vaccine was vaccinated by the President of the Republic, Alpha Conde. We welcome the regulator's decision to approve the vaccine and stand ready to support the Republic of Guinea in the fight against the pandemic."

Sputnik V is also registered in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, and the United Arab Emirates.